作者: Theresa Lopez , Douglas Hanahan
DOI: 10.1016/S1535-6108(02)00055-7
关键词:
摘要: In a prototypical model of multistage tumorigenesis involving pancreatic islets in RIP1-Tag2 transgenic mice, activation insulin-like growth factor II (IGF-II) was previously shown to serve as survival that inhibited apoptosis. Now IGF-1R, the receptor tyrosine kinase for IGF-II, has been found be variably upregulated, first uniformly dysplastic and angiogenic progenitors then focally at margins invasive regions carcinomas. When levels IGF-1R were forcibly elevated throughout islet tumorigenesis, progression accelerated all stages pathway, although apoptosis not differentially suppressed. Notably, encapsulated tumors absent; instead, carcinomas with downregulated E-cadherin prevalent, majority mice had local lymph node metastasis.